During the past decade, Central Sooner Research conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 24 clinical trials were completed, i.e. on average, 77.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 18 clinical trials were completed. i.e. 257.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Sooner Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Galderma R&D" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Sooner Research" #1 collaborator was "Allergan Sales, LLC" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Meiji Seika Pharma Co., Ltd." with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Veristat, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Central Sooner Research" are "Psoriasis" (9 trials), "Acne Vulgaris" (5 trials), "Ulcerative Colitis" (5 trials), "Plaque Psoriasis" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Central Sooner Research" in a lesser frequency.

Most popular intervention types in "Central Sooner Research" are "Drug" (50 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Vehicle" (6 trials), "BMS-986165" (3 trials), "Guselkumab" (3 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central Sooner Research" are 50 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Central Sooner Research". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Central Sooner Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Central Sooner Research, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".